Walleye Capital
VIR icon

Walleye Capital’s Vir Biotechnology VIR Stock Holding History

Walleye Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$896 Buy
+100
New +$797 ﹤0.01% 4265
2025
Q4 		– Sell
-10,600
Closed -$60.5K – 5177
2025
Q3 		$60.5K Sell
10,600
-2,300
-18% -$11.8K ﹤0.01% 3932
2025
Q2 		$65K Buy
+12,900
New +$69.2K ﹤0.01% 3947
2024
Q4 		– Sell
-4,400
Closed -$33K – 5606
2024
Q3 		$33K Buy
+4,400
New +$38.2K ﹤0.01% 4725
2023
Q4 		– Sell
-4,000
Closed -$37.5K – 5564
2023
Q3 		$37.5K Sell
4,000
-13,300
-77% -$190K ﹤0.01% 4264
2023
Q2 		$424K Sell
17,300
-2,500
-13% -$62.8K ﹤0.01% 2556
2023
Q1 		$461K Buy
+19,800
New +$506K 0.01% 1788

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return